methylprednisolone has been researched along with everolimus in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 5 (25.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 4 (20.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Böhler, T; Budde, K; Fritsche, L; Jauho, A; Korn, A; Lichter, S; Neumayer, HH; Waiser, J | 1 |
Alho, H; Harjula, AL; Ikonen, T; Maasilta, P; Salminen, US; Taskinen, E | 1 |
Harjula, AL; Lautenschlager, IT; Maasilta, PK; Salminen, US; Taskinen, EI | 1 |
Evenepoel, P; Geypens, B; Ghoos, Y; Kuypers, D; Maes, BD; Vanrenterghem, Y | 1 |
Alho, HS; Maasilta, PK; Päiväniemi, OE; Salminen, US; Wolff, CH | 1 |
Cretin, N; Dantal, J; Jappe, A; Li, Y; Margreiter, R; Viljoen, HG; Vítko, S; Weimar, W | 1 |
Carreño, CA; Gadea, M | 1 |
Mackenzie, M; Wood, LA | 1 |
De Vriese, AS; Vandecasteele, SJ; Vandewiele, B; Vanwalleghem, L | 1 |
Gerull, S; Halter, JP; Hostettler, KE; Lardinois, D; Roth, M; Savic, S; Tamm, M | 1 |
Bułanowski, M; Dębska-Ślizień, A; Rutkowski, B; Tarasewicz, A; Więcek, A | 1 |
Carmellini, M; Colussi, G; Ponticelli, C; Rigotti, P; Sandrini, S; Segoloni, G; Stefoni, S; Tisone, G | 1 |
Santai, S; Shikai, W; Tao, W; Xiangying, M; Zefei, J | 1 |
Chinen, K; Iseki, K; Ishida, H; Nagayama, K; Oroku, M; Ota, M; Shiohira, Y; Tanabe, K; Tsujimura, K | 1 |
Gulde, A; Hasanov, E; Krucke, GW; Krug, K | 1 |
Ateş, ÖF; Çetin, ES; Dheir, H; Fırat, N; Genç, AB; Karabay, O; Köroğlu, M; Muratdağı, G; Özmen, K; Sipahi, S; Tomak, Y; Yaylacı, S | 1 |
Endo, T; Fujisawa, M; Ishimura, T; Nishioka, S; Ogawa, S; Yokoyama, N | 1 |
Hirai, T; Inoue, T; Iwamoto, T; Mizuta, A; Nishikawa, K; Sasaki, T | 1 |
1 review(s) available for methylprednisolone and everolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for methylprednisolone and everolimus
Article | Year |
---|---|
The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
Topics: Cells, Cultured; Cyclosporine; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Methylprednisolone; Polyenes; Sirolimus; T-Lymphocytes | 1998 |
Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients.
Topics: Adolescent; Adult; Aged; Biopsy; Dose-Response Relationship, Drug; Double-Blind Method; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Safety; Sirolimus; Survival Analysis; Treatment Outcome | 2004 |
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids?
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Prospective Studies; Sirolimus; Treatment Failure | 2014 |
16 other study(ies) available for methylprednisolone and everolimus
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of rapamycin analogue SDZ RAD on obliterative lesions in a porcine heterotopic bronchial allograft model.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Epithelium; Everolimus; Immunosuppressive Agents; Methylprednisolone; Mucous Membrane; Necrosis; Polyenes; Sirolimus; Swine; Transplantation, Heterotopic; Transplantation, Homologous | 1998 |
Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Immune System; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Methylprednisolone; Sirolimus; Swine; Time Factors; Transplantation Immunology; Transplantation, Autologous; Transplantation, Homologous | 2001 |
Influence of SDZ RAD vs. MMF on gastric emptying in renal transplant recipients.
Topics: Breath Tests; Case-Control Studies; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Gastric Emptying; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Sirolimus; Time Factors | 2003 |
Cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Chondrocytes; Cyclooxygenase 2; Cyclosporine; Disease Models, Animal; Epithelial Cells; Everolimus; Fibroblasts; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Isoenzymes; Macrophages; Methylprednisolone; Postoperative Period; Prostaglandin-Endoperoxide Synthases; Sirolimus; Swine | 2004 |
Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
Topics: Adrenal Cortex Hormones; Azathioprine; Cryptogenic Organizing Pneumonia; Cyclosporine; Everolimus; Female; Humans; Kidney Transplantation; Methylprednisolone; Middle Aged; Papillomavirus Infections; Polycystic Kidney Diseases; Postoperative Complications; Sirolimus; Vaginal Neoplasms | 2007 |
Lingual angioedema associated with everolimus.
Topics: Angioedema; Anti-Allergic Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Diphenhydramine; Epinephrine; Everolimus; Humans; Kidney Neoplasms; Male; Methylprednisolone; Middle Aged; Sirolimus; Tongue Diseases | 2010 |
Diffuse alveolar hemorrhage induced by everolimus.
Topics: Biopsy; Bronchoscopy; Diagnosis, Differential; Dose-Response Relationship, Drug; Everolimus; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Hemoptysis; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Middle Aged; Sirolimus | 2010 |
Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Topics: Adult; Bronchiolitis Obliterans; Calcineurin Inhibitors; Cell Proliferation; Cells, Cultured; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Forced Expiratory Volume; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lung; Male; Methylprednisolone; Mycophenolic Acid; Myofibroblasts; Sirolimus; Tacrolimus | 2014 |
Everolimus in immunosuppressive treatment after kidney transplantation in a patient with tuberous sclerosis: case report.
Topics: Adult; Creatinine; Delayed Graft Function; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis | 2014 |
Treatment with everolimus for a patient with systemic metastatic breast cancer results in severe pulmonary injury: a case report.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Everolimus; Female; Glucocorticoids; Humans; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Effect of Influenza Vaccine in Patients With Kidney Transplant.
Topics: Adult; Cyclosporine; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Influenza Vaccines; Influenza, Human; Japan; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus | 2018 |
Everolimus-induced pneumonitis: A diagnostic challenge.
Topics: Androstadienes; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Ductal, Breast; Computed Tomography Angiography; Cough; Diagnosis, Differential; Dyspnea; Everolimus; Female; Glucocorticoids; Humans; Lung Neoplasms; Methylprednisolone; Middle Aged; Pneumonia; Pneumonia, Bacterial; Pulmonary Embolism; Pulse Therapy, Drug; Radiography, Thoracic; Tomography, X-Ray Computed | 2020 |
Clinical course of COVID-19 disease in immunosuppressed renal transplant patients
Topics: Acute Kidney Injury; Adult; COVID-19; Deprescriptions; Dexamethasone; Disease Progression; Everolimus; Female; Glucocorticoids; Graft Rejection; Hospital Mortality; Hospitalization; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Length of Stay; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Renal Dialysis; Respiration, Artificial; Respiratory Insufficiency; Retrospective Studies; SARS-CoV-2; Sepsis; Tacrolimus | 2021 |
No Influence of Everolimus on Mycophenolic Acid Area Under the Concentration-Time Curve: Limited Sampling Strategy for Mycophenolic Acid in Japanese Kidney Transplant Recipients Treated With Tacrolimus, Mycophenolate Mofetil, Steroid, and Everolimus.
Topics: Area Under Curve; Everolimus; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Methylprednisolone; Mycophenolic Acid; Tacrolimus | 2022 |
Drug-drug interaction between remdesivir and immunosuppressant agents in a kidney transplant recipient.
Topics: Adenosine Monophosphate; Alanine; COVID-19 Drug Treatment; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Interactions; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Tacrolimus | 2022 |